BrightEdge
Overview
BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society, investing in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Thatch | Feb 2023 | Seed | Co-investor |
| Freenome | Feb 2024 | VC Round | Co-investor |
| CellCentric | May 2026 | Series D | Co-investor |
| Nusano | Nov 2022 | Series B | Co-investor |
| Auron Therapeutics | Feb 2025 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Amy Berg 🟦
Principal, Philanthropy
Jack Chapon
Venture Capital Investment Intern
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BrightEdge based?
BrightEdge is headquartered in Atlanta, Georgia, United States.
When was BrightEdge founded?
BrightEdge was founded in 2018.
How many portfolio companies does BrightEdge have?
BrightEdge has 30 portfolio companies in Caplight's dataset.
What are some companies in BrightEdge's portfolio?
Portfolio companies visible on Caplight include Thatch, Freenome, CellCentric, Nusano, Auron Therapeutics.
What was BrightEdge's most recent investment shown here?
BrightEdge's most recent investment in this portfolio sample was in CellCentric in 2026.
What sectors does BrightEdge focus on?
BrightEdge focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Crypto & Web3, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Enterprise Software, Mobility, Transportation & Logistics, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, FinTech.
What company stages does BrightEdge focus on?
BrightEdge typically invests at the Early stage.
What is BrightEdge's AUM?
BrightEdge's assets under management are estimated between $80.3M and $80.3M.